Ajooni Biotech Limited (AJOONI.NS) NSE

Currency In INR

AD

Valuation

Market Cap1.84B
Enterprise Value2.02B
P/E Ratio13.78
PEG Ratio1.38
Price/Sales Ratio0.25
Price/Book Ratio0.58
Enterprise/Revenue0.37
Enterprise/EBITDA10.41

Fiscal Year

Fiscal YearMarch 31, 2026
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.02
Operating Margin0.02
AD

Management Effectiveness

Return On Assets0.03
Return On Equity0.04

Income Statement

Revenue1.82B
Revenue/Share12.46
Gross Profit276.71M
EBITDA62.56M
Net Income43.22M
Diluted EPS0.09

Balance Sheet

Total Cash3.74M
Total Cash/Share0.02
Total Debt269.11M
Total Debt/Equity0.29
Current Ratio2.36
Book Value Per Share5.32

Price History

52-Week Change-41.06
52-Week High5.5
52-Week Low3.02
Moving Average 50 Days3.65
Moving Average 200 Days4.05

Statistics

Average Volume359,304
Shares Outstanding172.24M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor567:500
Last Split DateNovember 25, 2022
AD